-
Detailed Analysis Generate Full Report Add to Watchlist
Values as of: 2019-07-15
Values as of: 2019-07-15
The investment seeks investment results that correspond generally to the price and yield performance of its underlying index, the IQ Real Return Index. The fund is a "fund of funds" which means it invests, under normal circumstances, at least 80% of its net assets, plus the amount of any borrowings for investment purposes, in the investments included in its underlying index, which includes underlying funds. The underlying index consists of a number of components ("underlying index Components") selected in accordance with the rules-based methodology of such underlying index.
Company Website : www.indexiq.com
Currency: USD
Country : USA
Inception Date: 27/10/2009
Primary Benchmark: IQ Real Return TR USD
Primary Index: Morningstar Mod Tgt Risk TR USD
Gross Expense Ratio: 0.49%
Management Expense Ratio: 0.37 %
N/A
N/A
N/A
N/A
| Symbol | Name | Mer | Price(Change) | Market Cap |
|---|---|---|---|---|
| SOJE | SOJE | 0.00 % |
+0.04 (+0.21%) |
USD 65.72B |
| JEPI | JPMorgan Equity Premium Income.. | 0.00 % |
-0.11 (-0.20%) |
USD 32.78B |
| LCR | Leuthold Core ETF | 0.00 % |
-0.09 (-0.27%) |
USD 32.52B |
| DTB | DTB | 0.00 % |
-0.12 (-0.63%) |
USD 26.58B |
| DFAC | Dimensional U.S. Core Equity 2.. | 0.00 % |
-0.03 (-0.10%) |
USD 26.11B |
| JPST | JPMorgan Ultra-Short Income ET.. | 0.00 % |
N/A |
USD 22.47B |
| SGOV | iShares® 0-3 Month Treasury B.. | 0.00 % |
+0.03 (+0.03%) |
USD 18.58B |
| TSPA | T. Rowe Price US Equity Resear.. | 0.00 % |
-0.07 (-0.22%) |
USD 16.23B |
| DFUV | Dimensional US Marketwide Valu.. | 0.00 % |
+0.04 (+0.10%) |
USD 10.15B |
| AVUV | Avantis® U.S. Small Cap Value.. | 0.00 % |
+0.02 (+0.02%) |
USD 10.05B |
| Market Performance vs. Industry/Classification (Others) | Market Performance vs. Exchange (NYSE Arca) | ||||||
| Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade | |
| YTD | |||||||
| Capital Gain | 5.00% | 26% | F | 28% | F | ||
| Dividend Return | N/A | N/A | N/A | N/A | F | ||
| Total Return | 5.00% | 22% | F | 24% | F | ||
| Trailing 12 Months | |||||||
| Capital Gain | 0.30% | 49% | F | 52% | F | ||
| Dividend Return | 1.25% | 32% | F | 22% | F | ||
| Total Return | 1.55% | 45% | F | 47% | F | ||
| Trailing 5 Years | |||||||
| Capital Gain | 4.97% | 54% | F | 56% | F | ||
| Dividend Return | 2.52% | 14% | F | 9% | A- | ||
| Total Return | 7.48% | 39% | F | 39% | F | ||
| Average Annual (5 Year Horizon) | |||||||
| Capital Gain | 0.88% | 100% | F | 45% | F | ||
| Dividend Return | 1.31% | 38% | F | 38% | F | ||
| Total Return | 0.44% | 13% | F | 12% | F | ||
| Risk Return Profile | |||||||
| Volatility (Standard Deviation) | 1.41% | 100% | F | 99% | N/A | ||
| Risk Adjusted Return | 93.16% | 100% | F | 91% | A- | ||
| Market Capitalization | 0.02B | 41% | F | 18% | F | ||
| Target Price Action | Rating Action | Analyst | Rating | Price | Date |
|---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
The company has under performed its peers on annual average total returns in the past 5 years.
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
